未登录

S

Sanjib Bhakta

University of London

H指数:36

被引数:3,577

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives

吡唑烷类抗分枝杆菌药物的设计与开发进展：最新进展与未来展望

IF4.6

2025-09-020

OA

Development of Carprofen analogues with activity against Mycobacterium tuberculosis

卡普洛芬类似物的开发及其对分枝杆菌的抗活性

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2025-06-070

PRE

Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics

IF4.6

2023-12-151

OAAI

Antimicrobial Peptides Designed against the Ω-Loop of Class A b-Lactamases to Potentiate the Efficacy of b-Lactam Antibiotics

ANTIBIOTICS-BASEL

IF4.6

2023-03-102

OA

C2-linked alkynyl poly-ethylene glycol(PEG) adenosine conjugates as water-soluble adenosine receptor agonists

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2022-08-221

OAAI

The Phytochemistry and Pharmacology of Tulbaghia, Allium, Crinum and Cyrtanthus: 'Talented' Taxa from the Amaryllidaceae

IF4.6

2022-07-135

OAAI

A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2022-02-014

OAAI

Role of AmpC-Inducing Genes in Modulating Other Serine Beta-Lactamases in Escherichia coli

ANTIBIOTICS-BASEL

IF4.6

2022-01-063

OA

Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-01-0414

OA

Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors

RSC MEDICINAL CHEMISTRY

IF3.6

2022-01-016

OAAI

Investigating Ghanaian Allium Species for Anti-Infective and Resistance-Reversal Natural Product Leads to Mitigate Multidrug-Resistance in Tuberculosis

调查加纳葱属物种的抗感染和耐药性逆转天然产物可减轻结核病的多药耐药性

ANTIBIOTICS-BASEL

IF4.6

2021-07-236

OAAI

Weighted Gene Co-Expression Network Analysis Identifies Key Modules and Hub Genes Associated with Mycobacterial Infection of Human Macrophages (vol 10, 97, 2021)

ANTIBIOTICS-BASEL

IF4.6

2021-06-290

OAAI

New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis

PHARMACEUTICALS

IF4.8

2021-04-1422

OAAI

Characterization of the MurT/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target

JAC-ANTIMICROBIAL RESISTANCE

IF3.3

2021-03-167

OAAI

Weighted Gene Co-Expression Network Analysis Identifies Key Modules and Hub Genes Associated with Mycobacterial Infection of Human Macrophages

ANTIBIOTICS-BASEL

IF4.6

2021-01-208

OA

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review

ANTIBIOTICS-BASEL

IF4.6

2021-01-1910

OA

The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-12-2936

OA

Bioactive Compounds from the Bornean Endemic Plant Goniothalamus longistipetes

来自婆罗洲特有植物Goniothalamus longistipetes的生物活性化合物

ANTIBIOTICS-BASEL

IF4.6

2020-12-163

OAAI

Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2020-08-1315

OAAI

Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones fromSphaeranthus africanusAgainst Mycobacteria

ANTIBIOTICS-BASEL

IF4.6

2020-07-0818

OA